« Back to Medicines list

Psoriderm Emulsion 40% w/v Bath Additive

  • Name:

    Psoriderm Emulsion 40% w/v Bath Additive

  • Company:
    info
  • Active Ingredients:

    Distilled Coal Tar

  • Legal Category:

    Supply through pharmacy only

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 10/03/15

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 31/8/2018

Click on this link to Download PDF directly

Dermal Laboratories Limited

Dermal Laboratories Limited

Company Products

Medicine NameActive Ingredients
Medicine Name Anhydrol Forte 20% w/v Cutaneous Solution Active Ingredients Aluminium Chloride Hexahydrate
Medicine Name Betacap Scalp Application 0.1% w/w Cutaneous Solution Active Ingredients Betamethasone Valerate
Medicine Name Capasal Therapeutic Shampoo Active Ingredients Coconut Oil, Distilled Coal Tar, Salicylic Acid
Medicine Name Dioderm 0.1% w/w Cream Active Ingredients Hydrocortisone
Medicine Name Dithrocream Active Ingredients Dithranol
Medicine Name Emulsiderm Emollient Bath Additive/Cutaneous Emulsion Active Ingredients Benzalkonium Chloride, Isopropyl Myristate, Liquid Paraffin
Medicine Name Exterol 5% w/w Ear Drops, Solution Active Ingredients Urea Hydrogen Peroxide
Medicine Name Glutarol 10% w/v Cutaneous Solution Active Ingredients Glutaraldehyde
Medicine Name Ibugel 5% w/w Gel Active Ingredients Ibuprofen
Medicine Name Nicam 4% w/w Gel Active Ingredients Nicotinamide
Medicine Name Perinal Cutaneous Spray Active Ingredients Hydrocortisone, Lidocaine Hydrochloride
Medicine Name Psoriderm Cream Active Ingredients Distilled Coal Tar
Medicine Name Psoriderm Emulsion 40% w/v Bath Additive Active Ingredients Distilled Coal Tar
Medicine Name Psoriderm Scalp Lotion Shampoo Active Ingredients Distilled Coal Tar
Medicine Name Salactol Collodion Active Ingredients Lactic Acid, Salicylic Acid
Medicine Name Salatac Gel Active Ingredients Lactic Acid, Salicylic Acid
1 - 0 of 16 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 31 August 2018 SmPC

Reasons for updating

  • File format updated to PDF

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

File format updated to PDF

Updated on 10 August 2015 SmPC

Reasons for updating

  • Correction of spelling/typing errors

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

In section 4.8 Undesirable effects, in the HPRA address "IRL - Dublin" has been updated to "IRL - Dublin 2"

Updated on 10 August 2015 SmPC

Reasons for updating

  • New SmPC for new product

Legal category: Supply through pharmacy only

Updated on 10 March 2015 PIL

Reasons for updating

  • Change to date of revision
  • Addition of information on reporting a side effect.
  • Removal/change of distributor

Updated on 10 March 2015 SmPC

Reasons for updating

  • Change to Section 4.8 – Undesirable effects - how to report a side effect
  • Change to section 10 - Date of revision of the text

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

In section 4.8 Undesirable effects, the following text has been added:

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important.  It allows continued monitoring of the benefit/risk balance of the medicinal product.  Healthcare professionals are asked to report any suspected adverse reactions via HPRA Pharmacovigilance, Earlsfort Terrace, IRL – Dublin; Tel: +353 1 6764971; Fax: +353 1 6762517.  Website: www.hpra.ie; E-mail:medsafety@hpra.ie.



In section 10 Date of revision of the text, the date has changed to "February 2015"

Updated on 10 March 2015 PIL

Reasons for updating

  • New PIL for new product

Updated on 11 August 2010 PIL

Reasons for updating

  • New PIL for medicines.ie

Updated on 26 March 2007 SmPC

Reasons for updating

  • Change to section 4.3 - Contraindications
  • Change to section 4.8 - Undesirable effects

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Section 4.3 - Contra-indications: Additional text added: "Not to be used for acute, sore or pustular psoriasis or in the presence of infection."
 
Section 4.8 - Undesirable effects: Additional text added: "In the rare event of skin irritation, acne-like eruptions or photosensitivity, discontinue treatment. Rarely, Psoriderm Emulsion Bath Additive may stain skin, hair or fabric."

Updated on 18 August 2006 SmPC

Reasons for updating

  • Change to section 1 - Name of medicinal product
  • Change to section 6.1 - List of excipients
  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Section 1 - Name of the Medicinal Product: Changed to "Psoriderm Emulsion 40% w/v Bath Additive"
 
Subsequently name changed in sections 4.9 Overdose, 5.1 Pharmacodynamic properties and 5.2 Pharmacokinetic properties.
 
Section 6.1 - List of excipients: "Triethanolamine" changed to "Trolamine"
 
Section 6.2 - Incompatibilities: "None known" changed to "Not applicable"
 
Section 6.6 - Instructions for use and handling: "No special instructions" changed to "No special requirements"
 
Section 9 - Renewal of the Authorisation: Changed to "1 December 2005"
 
Section 10 - Date of Revision of the Text: Changed to "February 2006"

Updated on 12 June 2003 SmPC

Reasons for updating

  • New SPC for medicines.ie

Legal category: Supply through pharmacy only